Riskpilot← Back to searchSign inGet full accessMalmö Tandläkarna AB
ABActiveOrg 5590536651Nikolaigatan 14Dental practice care activities · NACE 8623Est. 20168 employees
Revenue 2025
SEK 17,2M
-3% vs 2024
EBITDA margin
17.4%
-18% vs 2024
Equity ratio
45.9%
Financial strength
Net profit 2025
SEK 2,2M
-19% vs 2024
| Revenue | SEK 17,2M | -3% |
| EBITDA | SEK 3M | -18% |
| Net profit | SEK 2,2M | -19% |
| Total assets | SEK 4,9M | -11% |
| Equity | SEK 2,2M | -19% |
| Employees | 8 | — |
Legal name
Malmö Tandläkarna AB
Org number
5590536651
Legal form
Aktiebolag
NACE code
8623 · Dental practice care activities
Founded
3 mars 2016
Share capital
SEK 50 000
Employees
8 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget ska bedriva tandvård, handel med värdepapper och fastigheter och därmed förenlig verksamhet.
Address
Nikolaigatan 14
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 10 517 | 10 052 | 14 011 | 17 687 | 17 151 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 1 283 | 1 551 | 2 345 | 3 624 | 2 983 |
| Depreciation & amort. | −149 | −71 | −106 | −185 | −190 |
| EBIT | 1 134 | 1 480 | 2 239 | 3 439 | 2 793 |
| Net financials | −8 | −2 | 4 | 9 | 8 |
| Profit before tax | 1 126 | 1 478 | 2 242 | 3 448 | 2 801 |
| Tax | −263 | −333 | −560 | −761 | −628 |
| Net profit | 863 | 1 145 | 1 682 | 2 687 | 2 173 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 3 389 | 3 125 | 3 679 | 5 530 | 4 895 |
| Equity | 959 | 1 204 | 1 786 | 2 773 | 2 246 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 2 430 | 1 921 | 1 893 | 2 757 | 2 648 |
| Total debt | 2 430 | 1 921 | 1 893 | 2 757 | 2 648 |
EBITDA margin
17.4%
This company
15.8%
Market median
+10% vs market
20212025
Equity ratio
45.9%
This company
38.2%
Market median
+20% vs market
20212025
Return on equity
96.7%
This company
18.4%
Market median
+426% vs market
20212025
Net profit margin
12.7%
This company
8.1%
Market median
+57% vs market
20212025
Asset turnover
3.50×
This company
1.12×
Market median
+212% vs market
20212025
Debt / equity
1.18×
This company
0.62×
Market median
-90% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MA | Audit | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Nident AB
Malmö Tandläkarna AB Board members of Malmö Tandläkarna AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mats Anders Gyllenberg | Audit | 0 companies |
| Nazar Mohammed Arif Al-Juboori | Deputy Board Member | 0 companies |
| Meena Al-Buiruty | Board of Directors | 0 companies |